iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS – Get Free Report)’s share price reached a new 52-week low on Wednesday. The company traded as low as $24.11 and last traded at $24.12, with a volume of 442663 shares. The stock had previously closed at $24.12.
iShares iBonds Dec 2027 Term Corporate ETF Trading Down 0.3%
The firm has a 50-day simple moving average of $24.15 and a 200-day simple moving average of $24.17.
Institutional Investors Weigh In On iShares iBonds Dec 2027 Term Corporate ETF
Institutional investors have recently added to or reduced their stakes in the stock. Ascentis Independent Advisors bought a new position in iShares iBonds Dec 2027 Term Corporate ETF in the first quarter worth about $85,000. NBH Bank bought a new stake in shares of iShares iBonds Dec 2027 Term Corporate ETF in the 2nd quarter valued at about $85,000. Front Row Advisors LLC grew its position in shares of iShares iBonds Dec 2027 Term Corporate ETF by 39.3% in the 1st quarter. Front Row Advisors LLC now owns 5,850 shares of the company’s stock worth $142,000 after buying an additional 1,650 shares during the last quarter. Bogart Wealth LLC grew its position in shares of iShares iBonds Dec 2027 Term Corporate ETF by 47.6% in the 1st quarter. Bogart Wealth LLC now owns 8,285 shares of the company’s stock worth $201,000 after buying an additional 2,673 shares during the last quarter. Finally, Bessemer Group Inc. bought a new position in shares of iShares iBonds Dec 2027 Term Corporate ETF during the 1st quarter worth approximately $234,000.
About iShares iBonds Dec 2027 Term Corporate ETF
The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg global index of USD-denominated, investment-grade corporate bonds maturing between December 31, 2026 and December 16, 2027. IBDS was launched on Sep 12, 2017 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares iBonds Dec 2027 Term Corporate ETF
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for iShares iBonds Dec 2027 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2027 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.
